Matinas BioPharma Holdings Inc (MTNB)
0.1711
0.00 (0.00%)
USD |
NYAM |
May 17, 16:00
0.1741
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Market Cap: 42.64M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 42.64M |
| May 16, 2024 | 43.39M |
| May 15, 2024 | 43.29M |
| May 14, 2024 | 44.07M |
| May 13, 2024 | 42.79M |
| May 10, 2024 | 44.04M |
| May 09, 2024 | 44.32M |
| May 08, 2024 | 44.52M |
| May 07, 2024 | 42.89M |
| May 06, 2024 | 42.14M |
| May 03, 2024 | 43.87M |
| May 02, 2024 | 45.97M |
| May 01, 2024 | 45.80M |
| April 30, 2024 | 46.58M |
| April 29, 2024 | 46.02M |
| April 26, 2024 | 44.87M |
| April 25, 2024 | 45.52M |
| April 24, 2024 | 45.60M |
| April 23, 2024 | 45.52M |
| April 22, 2024 | 45.15M |
| April 19, 2024 | 47.08M |
| April 18, 2024 | 47.66M |
| April 17, 2024 | 48.16M |
| April 16, 2024 | 50.14M |
| April 15, 2024 | 50.79M |
| Date | Value |
|---|---|
| April 12, 2024 | 50.97M |
| April 11, 2024 | 50.59M |
| April 10, 2024 | 52.42M |
| April 09, 2024 | 53.40M |
| April 08, 2024 | 52.42M |
| April 05, 2024 | 53.37M |
| April 04, 2024 | 47.72M |
| April 03, 2024 | 49.48M |
| April 02, 2024 | 76.12M |
| April 01, 2024 | 80.43M |
| March 28, 2024 | 58.94M |
| March 27, 2024 | 63.05M |
| March 26, 2024 | 62.13M |
| March 25, 2024 | 63.11M |
| March 22, 2024 | 60.46M |
| March 21, 2024 | 57.89M |
| March 20, 2024 | 62.64M |
| March 19, 2024 | 61.72M |
| March 18, 2024 | 59.26M |
| March 15, 2024 | 65.18M |
| March 14, 2024 | 51.73M |
| March 13, 2024 | 55.40M |
| March 12, 2024 | 56.49M |
| March 11, 2024 | 58.88M |
| March 08, 2024 | 58.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.64M
Minimum
Oct 03 2023
376.89M
Maximum
Jan 02 2020
148.69M
Average
151.76M
Median
May 25 2022
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 4.487M |
| Palatin Technologies Inc | 32.27M |
| iBio Inc | 6.899M |
| Theriva Biologics Inc | 6.405M |
| Oragenics Inc | 10.44M |
Market Cap Related Metrics
| PS Ratio | 8.620 |
| Price to Book Value | 2.929 |
| Price | 0.1711 |
| Earnings Yield | -70.59% |